Keros Therapeutics, Inc. (KROS) — Analyst estimates
Consensus analyst estimates for Keros Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 778.57K | -1.79 | 2 |
| 2027 | 433.33K | -1.79 | 2 |
| 2028 | 677.9K | -2.29 | 3 |
| 2029 | 58.30M | -4.25 | 2 |
| 2030 | 107.7M | -1.98 | 5 |
Consensus analyst estimates by fiscal year.